Interviews with Indigenous Māori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trial
Open Access
- 23 March 2023
- journal article
- research article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 22 (1) , 861-871
Abstract
Purpose: Open-source automated insulin delivery (AID) is used by thousands of people with type 1 diabetes (T1D), but has unknown generalisability to marginalised ethnic groups. This study explored experiences of Indigenous Māori participants in the CREATE trial with use of an open-source AID system to identify enablers/barriers to health equity. Methods: The CREATE randomised trial compared open-source AID (OpenAPS algorithm on an Android phone with a Bluetooth-connected pump) to sensor-augmented pump therapy. Kaupapa Māori Research methodology was used in this sub-study. Ten semi-structured interviews with Māori participants (5 children, 5 adults) and whānau (extended family) were completed. Interviews were recorded and transcribed, and data were analysed thematically. NVivo was used for descriptive and pattern coding. Results: Enablers/barriers to equity aligned with four themes: access (to diabetes technologies), training/support, operation (of open-source AID), and outcomes. Participants described a sense of empowerment, and improved quality of life, wellbeing, and glycaemia. Parents felt reassured by the system’s ability to control glucose, and children were granted greater independence. Participants were able to use the open-source AID system with ease to suit whānau needs, and technical problems were manageable with healthcare professional support. All participants identified structures in the health system precluding equitable utilisation of diabetes technologies for Māori. Conclusion: Māori experienced open-source AID positively, and aspired to use this therapy; however, structural and socio-economic barriers to equity were identified. This research proposes strength-based solutions which should be considered in the redesign of diabetes services to improve health outcomes for Māori with T1D. Trial Registration: The CREATE trial, encompassing this qualitative sub-study, was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12620000034932p) on the 20th January 2020.Keywords
Funding Information
- Australasian Paediatric Endocrine Group (Sanofi Grant)
- University of Otago
This publication has 25 references indexed in Scilit:
- District health board of residence, ethnicity and socioeconomic status all impact publicly funded insulin pump uptake in New Zealand patients with type 1 diabetes2019
- Achieving health equity in Aotearoa: strengthening responsiveness to M?ori in health research.2017
- Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trialsThe Lancet Diabetes & Endocrinology, 2017
- Indigenous Positioning in Health Research: The importance of Kaupapa Māori theory-informed practiceAlterNative: An International Journal of Indigenous Peoples, 2016
- Demographic and regional disparities in insulin pump utilization in a setting of universal funding: a New Zealand nationwide studyActa Diabetologica, 2016
- Real-World Use of Open Source Artificial Pancreas SystemsJournal of Diabetes Science and Technology, 2016
- Minority groups and the artificial pancreas: who is (not) in line?The Lancet Diabetes & Endocrinology, 2016
- Social Determinants of Health on Glycemic Control in Pediatric Type 1 DiabetesThe Journal of Pediatrics, 2013
- Ethnicity and social deprivation independently influence metabolic control in children with type 1 diabetesDiabetologia, 2008
- Quality of hospital care for Māori patients in New Zealand: retrospective cross-sectional assessmentThe Lancet, 2006